Professor Richard Scolyer of the University of Sydney said he “couldn’t be happier” after learning that his glioblastoma was still showing no signs of recurrence from a recent MRI.
After suffering a seizure in Poland in June of last year, Prof. Scolyer—whose revolutionary melanoma treatment is credited with saving thousands of lives—was discovered to have a tumor.
Using the basis of his groundbreaking work on melanoma, he became the first brain cancer patient in history to get pre-surgery combination immunotherapy.
Given that the grade four brain tumor he had had a six-month median time to recur, Prof. Scolyer is now optimistic that the tumor won’t come back.
